Cargando…

PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer

BACKGROUND: Research has revealed that Plexin domain containing 1 (PLXDC1) is correlated with the prognosis of a variety of tumors, but its role in the tumor microenvironment (TME) of gastric cancer has not been reported. METHODS: In this study, we analyzed PLXDC1 expression in gastric cancer using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xinwei, Fan, Yongfei, Tang, Mingyue, Li, Huiyuan, Zhang, Yue, Mi, Jiaqi, Wang, Yanyan, Zhao, Menglin, Wang, Zishu, Su, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488617/ https://www.ncbi.nlm.nih.gov/pubmed/36147688 http://dx.doi.org/10.2147/JIR.S383191

Ejemplares similares

CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma
por: Li, Xinwei, et al.
Publicado: (2022)

The Upregulation of PLXDC2 Correlates with Immune Microenvironment Characteristics and Predicts Prognosis in Gastric Cancer
por: Li, Yang, et al.
Publicado: (2021)

Identification of PLXDC1 and PLXDC2 as the transmembrane receptors for the multifunctional factor PEDF
por: Cheng, Guo, et al.
Publicado: (2014)

C5aR1 shapes a non-inflammatory tumor microenvironment and mediates immune evasion in gastric cancer
por: Shen, Honghong, et al.
Publicado: (2023)

Effective clinical response of lung adenocarcinoma harboring EGFR 19Del/T790M/in cis-C797S osimertinib to osimertinib and gefitinib combination therapy
por: Wang, Yanyan, et al.
Publicado: (2023)

VEGF Mediates Tumor Growth and Metastasis by Affecting the Expression of E-Cadherin and N-Cadherin Promoting Epithelial to Mesenchymal Transition in Gastric Cancer
por: Zhang, Yue, et al.
Publicado: (2023)

Plxdc2 Is a Mitogen for Neural Progenitors
por: Miller-Delaney, Suzanne F. C., et al.
Publicado: (2011)

The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/CDK6-cyclin D1 and CXCR4/RhoA pathways
por: Zhao, Menglin, et al.
Publicado: (2022)

Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model
por: Shen, Honghong, et al.
Publicado: (2023)

Overexpression of PLXDC2 in Stromal Cell-Associated M2 Macrophages Is Related to EMT and the Progression of Gastric Cancer
por: Guan, Yiming, et al.
Publicado: (2021)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

PLXDC2 enhances invadopodium formation to promote invasion and metastasis of gastric cancer cells via interacting with PTP1B
por: Wu, Bin, et al.
Publicado: (2022)

Plxdc family members are novel receptors for the rhesus monkey rhadinovirus (RRV)
por: Großkopf, Anna K., et al.
Publicado: (2021)

Glioblastoma endothelium drives bevacizumab‐induced infiltrative growth via modulation of PLXDC1
por: Falchetti, Maria Laura, et al.
Publicado: (2018)

Effective treatment of MET-amplified non-small cell lung cancer patients with crizotinib: a case description
por: Tang, Mingyue, et al.
Publicado: (2023)

Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer
por: Sui, Minghua, et al.
Publicado: (2017)

ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma
por: Wang, Yanyan, et al.
Publicado: (2022)

Positive Phospho-Focal Adhesion Kinase in Gastric Cancer Associates With Poor Prognosis After Curative Resection
por: Peng, Ke, et al.
Publicado: (2022)

PFKFB4 as a promising biomarker to predict a poor prognosis in patients with gastric cancer
por: Wang, Fang, et al.
Publicado: (2021)

High expression of eIF3d is associated with poor prognosis in patients with gastric cancer
por: He, Jiaqi, et al.
Publicado: (2017)

Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse-type gastric cancer
por: Li, Sheng, et al.
Publicado: (2021)

Plexin domain containing 2 (PLXDC2) gene polymorphism rs7081455 may not influence POAG risk in a Saudi cohort
por: Kondkar, Altaf A., et al.
Publicado: (2018)

Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer
por: Lang, Liwei, et al.
Publicado: (2023)

Low REST Expression Indicates a Biomarker of Poor Prognosis in Patients with Renal Cell Carcinoma
por: Lv, Chaoxiang, et al.
Publicado: (2021)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Intratumoral TIGIT(+) CD8(+) T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer
por: Liu, Zhaopei, et al.
Publicado: (2020)

SWATH‐based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours
por: López‐Sánchez, Laura M., et al.
Publicado: (2019)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response
por: Wang, Guangyu, et al.
Publicado: (2021)

Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer
por: Wu, Mengjie, et al.
Publicado: (2020)

High expression of VCAN is an independent predictor of poor prognosis in gastric cancer
por: Li, Wenfei, et al.
Publicado: (2020)

Immune evasion mechanisms and therapeutic strategies in gastric cancer
por: Ma, En-Si, et al.
Publicado: (2022)

Decreased expression of STING predicts poor prognosis in patients with gastric cancer
por: Song, Shushu, et al.
Publicado: (2017)

Prognostic Model and Tumor Immune Microenvironment Analysis of Complement-Related Genes in Gastric Cancer
por: Gu, Xianhua, et al.
Publicado: (2023)

Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Postoperative fever predicts poor prognosis of gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
por: Huang, Ke, et al.
Publicado: (2022)

Low STYK1 expression indicates poor prognosis in gastric cancer
por: Fang, Jian, et al.
Publicado: (2018)

High expression of fibronectin 1 indicates poor prognosis in gastric cancer
por: Sun, Yang, et al.
Publicado: (2020)

Upregulation of KIF20A correlates with poor prognosis in gastric cancer
por: Sheng, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_81g36e4jn4grlq6es8snns2njo